Shirley Lyons has over 25 years of experience in the pharmaceutical industry primarily focusing on the medical device aspects of dry powder inhalers. Shirley is currently the Director of Device and Quality Systems Development at Respira Therapeutics, Inc. which she joined in 2017. Prior to joining Respira, she worked in the quality group at Novartis Pharmaceutical responsible for the medical device quality systems in San Carlos, CA (2009-2016). During her time with the company successfully completed Pre-Approval Inspections with health authorities in support of TOBI Podhaler. Shirley held various positions in device development at Nektar Therapeutics (formerly Inhale Therapeutic Systems) (1992-1999 & 2001-2008).